About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Brca1tm2Mak
targeted mutation 2, Tak W Mak
MGI:2429692
Summary 10 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3834729
cn2
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Trp53tm1Brd/Trp53tm1Brd
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3834730
cn3
Brca1tm2Mak/Brca1tm2Mak
Tg(BCL2)36Wehi/?
Tg(Lck-cre)548Jxm/?
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3834731
cn4
Brca1tm2Mak/Brca1tm2Mak
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Tg(Lck-cre)548Jxm/?
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3834732
cn5
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Tg(TcrLCMV)327Sdz/?
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3834733
cn6
Brca1tm2Mak/Brca1tm2Mak
Chek2tm1Mak/Chek2tm1Mak
Tg(Lck-cre)548Jxm/?
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3834734
cn7
Brca1tm2Mak/Brca1tm2Mak
Tg(Wap-cre)11738Mam/?
involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL MGI:3834735
cn8
Brca1tm2Mak/Brca1tm2Mak
Chek2tm1Mak/Chek2tm1Mak
Tg(Wap-cre)11738Mam/?
involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL MGI:3834736
cn9
Brca1tm2Mak/Brca1tm2Mak
Trp53tm1Brd/Trp53+
Tg(Wap-cre)11738Mam/?
involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL MGI:3834737
cn10
Brca1tm2Mak/Brca1tm2Mak
Trp53tm1Brd/Trp53tm1Brd
Tg(Wap-cre)11738Mam/?
involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL MGI:3834738


Genotype
MGI:3834729
cn1
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Tg(Lck-cre)548Jxm mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• reduced proliferation when stimulated with monoclonal antibody to CD3e
• increased proportion of double negative thymocytes
• absolute number of double negative thymocytes is normal
• less than 10% of number in controls
• less than 10% of number in controls
• 90% reduction in thymocyte number

cellular
• fewer T cells entering S phase
• reduced viability of thymocytes in culture
• reduced survival of T cells when stimulated with monoclonal antibody to CD3e
• increased thymocyte sensitivity of gamma-irradiation
• reduced proliferation when stimulated with monoclonal antibody to CD3e

neoplasm
• only about 12% with tumors
• most tumors are peripheral rather than thymic

hematopoietic system
• reduced proliferation when stimulated with monoclonal antibody to CD3e
• 90% reduction in thymocyte number
• increased proportion of double negative thymocytes
• absolute number of double negative thymocytes is normal
• less than 10% of number in controls
• less than 10% of number in controls

endocrine/exocrine glands
• 90% reduction in thymocyte number




Genotype
MGI:3834730
cn2
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Trp53tm1Brd/Trp53tm1Brd
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Tg(Lck-cre)548Jxm mutation (2 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• increased incidence
• reduced latency

mortality/aging
• most mice with thymic lymphomas are moribund or die by 3 months of age

cellular
• increased frequency of aberrations such as polyploidy, quadriradial chromosomes, and telomeric translocations

immune system
N
• thymus cellularity restored
• T cell numbers in lymph nodes are improved

neoplasm
• increased incidence
• reduced latency




Genotype
MGI:3834731
cn3
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Tg(BCL2)36Wehi/?
Tg(Lck-cre)548Jxm/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Tg(BCL2)36Wehi mutation (3 available)
Tg(Lck-cre)548Jxm mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• increased frequency of aberrations such as polyploidy, quadriradial chromosomes, and telomeric translocations

immune system
N
• thymus cellularity restored




Genotype
MGI:3834732
cn4
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Tg(Lck-cre)548Jxm/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Cdkn1atm1Tyj mutation (3 available); any Cdkn1a mutation (60 available)
Tg(Lck-cre)548Jxm mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• T cell numbers in lymph nodes are more nearly normal

hematopoietic system

endocrine/exocrine glands




Genotype
MGI:3834733
cn5
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Tg(TcrLCMV)327Sdz/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Tg(Lck-cre)548Jxm mutation (2 available)
Tg(TcrLCMV)327Sdz mutation (8 available)
phenotype observed in females
phenotype observed in males
N normal phenotype



Genotype
MGI:3834734
cn6
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Chek2tm1Mak/Chek2tm1Mak
Tg(Lck-cre)548Jxm/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Chek2tm1Mak mutation (1 available); any Chek2 mutation (53 available)
Tg(Lck-cre)548Jxm mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• 32% with lymphomas by 180 days of age
• tumors are restricted to the thymus

immune system
N
• complete thymocyte restoration
• T cell numbers in the periphery are restored

cellular
N
• resistant to gamma irradiation
• restoration of normal cell cycle arrest of T cells when stimulated with antibody to CD3e or CD3 and Il2
• increased frequency

neoplasm
• 32% with lymphomas by 180 days of age
• tumors are restricted to the thymus




Genotype
MGI:3834735
cn7
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Tg(Wap-cre)11738Mam/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Tg(Wap-cre)11738Mam mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• only a mild predisposition to mammary cancer (12%)

integument
• only a mild predisposition to mammary cancer (12%)

endocrine/exocrine glands
• only a mild predisposition to mammary cancer (12%)




Genotype
MGI:3834736
cn8
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Chek2tm1Mak/Chek2tm1Mak
Tg(Wap-cre)11738Mam/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Chek2tm1Mak mutation (1 available); any Chek2 mutation (53 available)
Tg(Wap-cre)11738Mam mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• about 50% develop acinar adenocarcenomas

endocrine/exocrine glands
• about 50% develop acinar adenocarcenomas

integument
• about 50% develop acinar adenocarcenomas




Genotype
MGI:3834737
cn9
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Trp53tm1Brd/Trp53+
Tg(Wap-cre)11738Mam/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Tg(Wap-cre)11738Mam mutation (3 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• about 80% develop acinar adenocarcenomas

integument
• about 80% develop acinar adenocarcenomas

endocrine/exocrine glands
• about 80% develop acinar adenocarcenomas




Genotype
MGI:3834738
cn10
Allelic
Composition
Brca1tm2Mak/Brca1tm2Mak
Trp53tm1Brd/Trp53tm1Brd
Tg(Wap-cre)11738Mam/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Mak mutation (1 available); any Brca1 mutation (113 available)
Tg(Wap-cre)11738Mam mutation (3 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• usually succumb early to other tumors before developing mammary tumors





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory